ArticleMolecular cancer therapeutics2012

MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.

Chandra Bartholomeusz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.